Preoxygenation Recommendations in the 2026 ATS Guideline: Concerns About Trial Characterization and Evidence Asymmetry.

Qin H, Xia Y, Jiao Y, Dong YC, Zhang W.

Open source

DOI
10.1093/ajrccm/aamag466
Published
2026-09-15
Container
Am J Respir Crit Care Med
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ajrccm/aamag466,
  title = {Preoxygenation Recommendations in the 2026 ATS Guideline: Concerns About Trial Characterization and Evidence Asymmetry.},
  author = {Qin H and  Xia Y and  Jiao Y and  Dong YC and  Zhang W.},
  year = {2026},
  journal = {Am J Respir Crit Care Med},
  doi = {10.1093/ajrccm/aamag466},
  url = {https://doi.org/10.1093/ajrccm/aamag466}
}

RIS

TY  - JOUR
TI  - Preoxygenation Recommendations in the 2026 ATS Guideline: Concerns About Trial Characterization and Evidence Asymmetry.
AU  - Qin H
AU  -  Xia Y
AU  -  Jiao Y
AU  -  Dong YC
AU  -  Zhang W.
PY  - 2026
JO  - Am J Respir Crit Care Med
DO  - 10.1093/ajrccm/aamag466
UR  - https://doi.org/10.1093/ajrccm/aamag466
ER  - 

APA

H, Q., Y, X., Y, J., YC, D., & W., Z. (2026). Preoxygenation Recommendations in the 2026 ATS Guideline: Concerns About Trial Characterization and Evidence Asymmetry.. Am J Respir Crit Care Med. https://doi.org/10.1093/ajrccm/aamag466

Source records